ClinicaliQ Trial Snapshot
- The CATALINA Study — Recruiting • Respiratory / COPD / Asthma • NCT05008081.
- What is being tested: CATALINA is collecting standardised longitudinal clinical data and biological samples from COPD patients across multiple European centres to identify patterns and risk factors associated with exacerbations and disease progression.
- Patient eligibility overview: The study recruits COPD patients from 20 centres across Europe and beyond within the CICERO collaborative framework, though specific inclusion/exclusion criteria are not detailed in this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research Collaboration), designed to collect standardised, longitudinal clinical data and biological samples in 20 centres across Europe and beyond.
Eligibility Snapshot
- : * Age 18 years and older * Established diagnosis of COPD by medical doctor (based on clinical history OR pulmonary function test with an FEV1/FVC < 0.7) * Current hospitalization with suspicion of an acute exacerbation of COPD (AECOPD) * Inclusion within 48 hours post hospital admission * Voluntary written informed consent of the participant or his/her representative obtained prior to any study procedure
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.